Related references
Note: Only part of the references are listed.Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis
Guillaume Pineton de Chambrun et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study
Elise M. van Praag et al.
JOURNAL OF CROHNS & COLITIS (2020)
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
Hadrien Alric et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Developing a core outcome set for fistulising perianal Crohn's disease
Kapil Sahnan et al.
GUT (2019)
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study (vol 13, pg S569, 2019)
G. Pineton de Chambrun et al.
JOURNAL OF CROHNS & COLITIS (2019)
Vedolizumab for chronic antibiotic-refractory pouchitis
Amandeep Singh et al.
GASTROENTEROLOGY REPORT (2019)
Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
Tal Engel et al.
DIGESTIVE AND LIVER DISEASE (2019)
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis
Jacob E. Ollech et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
B. E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Bruce E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience
Bram Verstockt et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
Anal fistula plug vs rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysis of studies with long-term follow-up
H. Lin et al.
COLORECTAL DISEASE (2019)
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
Yoram Bouhnik et al.
GUT (2018)
A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions
Amy L. Lightner et al.
DISEASES OF THE COLON & RECTUM (2018)
An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients
Pawel Kawalec et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)
Risk of thrombosis and mortality in inflammatory bowel disease
Adriana R. Andrade et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm
J. P. Segal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update
Silvio Danese et al.
JOURNAL OF CROHNS & COLITIS (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
SURGICAL MANAGEMENT OF FISTULA-IN-ANO AMONG PATIENTS WITH CROHN'S DISEASE: ANALYSIS OF OUTCOMES AFTER FISTULOTOMY OR SETON PLACEMENT-SINGLE-CENTER EXPERIENCE
I. Papaconstantinou et al.
SCANDINAVIAN JOURNAL OF SURGERY (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
French national consensus clinical guidelines for the management of Crohn's disease
Laurent Peyrin-Biroulet et al.
DIGESTIVE AND LIVER DISEASE (2017)
Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study
Anne-Laure Mallet et al.
DIGESTIVE AND LIVER DISEASE (2017)
A Meta-analysis of Percutaneous Drainage Versus Surgery as the Initial Treatment of Crohn's Disease-related Intra-abdominal Abscess
Cillian Clancy et al.
JOURNAL OF CROHNS & COLITIS (2016)
French national consensus clinical guidelines for the management of ulcerative colitis
Laurent Peyrin-Biroulet et al.
DIGESTIVE AND LIVER DISEASE (2016)
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
Julian Panes et al.
LANCET (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-The McGill experience
U. Kopylov et al.
JOURNAL OF CROHNS & COLITIS (2014)
Comparison of the long-term outcome of two therapeutic strategies for the management of abdominal abscess complicating Crohn's disease: percutaneous drainage or immediate surgical treatment
T. Lobaton et al.
COLORECTAL DISEASE (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Share Paper
